[Form 4] Inogen Inc Insider Trading Activity
Inogen Inc executive Mary E. Wright, the VP and Chief Accounting Officer, reported several equity compensation transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Inogen Inc executive Mary E. Wright, the VP and Chief Accounting Officer, reported several equity compensation transactions. On March 1, 2026, multiple restricted stock unit tranches, including 1,755, 2,750 and 3,001 units, were exercised or converted into common stock at no cash cost. She also received common stock grants of 1,500 and 1,351 shares, while 675, 520, 1,058 and 1,155 shares of common stock at $6.10 were withheld to cover tax liabilities on the vesting awards. A separate grant of 8,000 restricted stock units was awarded on February 27, 2026, with vesting over several years subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 1,755 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 2,750 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 3,001 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,500 | $6.10 | $9K |
| Exercise | Common Stock | 1,755 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 675 | $6.10 | $4K |
| Grant/Award | Common Stock | 1,351 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 520 | $6.10 | $3K |
| Exercise | Common Stock | 2,750 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,058 | $6.10 | $6K |
| Exercise | Common Stock | 3,001 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,155 | $6.10 | $7K |
| Grant/Award | Restricted Stock Unit | 8,000 | $0.00 | $0.00 |
Footnotes (9)
- F1. Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
- F2. The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
- F3. The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on February 28, 2023.
- F4. The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on February 28, 2023 and vested on March 1, 2026.
- F5. Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- F6. Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
- F7. The restriced stock units were fully vested on March 1, 2026.
- F8. 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
- F9. 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
